Stay updated on Upadacitinib vs Abatacept in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Abatacept in RA Clinical Trial page
- Check2 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor system or template update. This update does not alter the study details or user-facing content on the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3. This indicates a small platform update rather than a change to the study information.SummaryDifference0.0%

- Check38 days agoChange Detected- The Sweden location entry now uses Malmö (with the diacritic) instead of Malmo, aligning the listing with the official city spelling. The postal code remains 214 28 and the rest of the details are unchanged.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/content-system version change rather than any change to the trial information.SummaryDifference0.0%

- Check52 days agoChange DetectedKrakow, Lesser Poland Voivodeship, Poland, 30-149 is replaced by Cracow, Lesser Poland Voivodeship, Poland, 30-149. București is replaced by Bucharest, and a new Bucharest, Bucharest, Romania, 020475 entry is added; Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Abatacept in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.